Biotechnology stocks have been back in the spotlight since the beginning of the year. Successes in research and market approvals for new drugs could provide fresh impetus. Is the sector worth a look now?
THIS AUTHOR'S POSTS
Turkish economy on the road to normalization
After years of numerous hardships, the political and economic signs are changing in Turkey. Growth, which has returned this year despite high inflation and interest rates, is expected to continue in the coming years according to forecasts. International investors have also rediscovered the Turkish stock market.
Biotechnology shares ready to stage a comeback?
In the first half of 2023, growth shares – and as such, also the biotechnology sector – came under pressure as investors were pivoting towards value shares. But the signs are changing. The possible high in interest rates in Europe and the USA could boost biotech shares again, as ERSTE STOCK BIOTEC fund manager Harald Kober explains in an interview.
Compound interest – how to make interest work for you
Interest ensures that the money in the savings account or invested in securities grows. If you have already saved or invested some money, you will receive interest on the interest again. This is compound interest. Compound interest makes your money grow even faster, especially if you don’t touch the money for years and interest rates are high.
“The demand for affordable housing remains high”
ERSTE IMMOBILIENFONDS is celebrating its 15th anniversary this month. The portfolio now comprises 85 properties in 10 cities with real estate assets of around EUR 2 billion. In this interview, Peter Karl, CEO of ERSTE Immobilien KAG, talks about the development of the fund and the challenges on the real estate markets in the face of rising interest rates and high inflation.
Five pieces of advice for saving with a fund savings plan
Putting money aside is important. But it is equally important for said money to potentially earn a return. This is where the fund savings plan comes in.
Ukraine war: Exclusive interview with ORF correspondent Christian Wehrschütz
Hardly any journalist like Christian Wehrschütz has been dealing so intensively with the background of the Ukraine war for years. In an exclusive interview, the ORF correspondent gave us insights into daily life in the midst of a war. He does not currently see a solution to the conflict in the near future.
Economy and interest rates in the context of global risks
What do global risks and rising interest rates mean for the economy? We talked to
Prof. Dr. Ernest Gnan, Secretary General of SUERF – The European Money and Finance Forum and former Head of the Economic Analysis Department of the Oesterreichische Nationalbank.
Despite correction: long-term upward trend of biotech companies intact
Biotechnology shares have seen better times. Despite the most recent corrections, hopes for growth in the biotechnology sector remain very high. We spoke to Harald Kober, fund manager of ERSTE STOCK BIOTEC, about the latest developments.
Outlook 2022: Erste Asset Management optimistic – recovery continues despite Covid, inflation, and supply bottlenecks
Compared with previous recessions, we came out of the last crisis relatively quickly. What were the decisive factors, what will drive the financial markets in 2022 and, above all, what role will inflation play? Erste AM Managing Director Heinz Bednar and Chief Investment Officer Gerold Permoser provide an outlook for the coming year.